Article
Prognostic impact of TTF-1 expression in patients with stage IV lung adenocarcinomas.
Lung cancer (Amsterdam, Netherlands) - 1 Jun 2017
Schilsky Juliana B, Ni Ai, Ahn Linda, Datta Sutirtha, Travis William D, Kris Mark G, Chaft Jamie E, Rekhtman Natasha, Hellmann Matthew D
Abstract excerpt
OBJECTIVES: Thyroid transcription factor 1 (TTF-1) is routinely tested in the diagnostic evaluation of suspected lung cancers, is commonly expressed by lung adenocarcinomas, and may modulate lung cancer biology. We examined the role of TTF-1 as a predictive and prognostic marker in patients with advanced lung adenocarcinomas. MATERIALS AND METHODS: We analyzed clinical, pathologic, and molecular features,...
Topics
Join the communities discussing this publication.
